English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
インデックス付き
- Google スカラー
- レフシーク
- ハムダード大学
- エブスコ アリゾナ州
- パブロン
- ICMJE
役立つリンク
オープンアクセスジャーナル
このページをシェアする
抽象的な
Immediate Breast Reconstructions after Mastectomy due to Breast Cancers with the Use of Serasynth and Seragynbr Synthetic Meshes. Single-Oncological Center Experience, Analysis of Complications
Aleksander Grous, Slawomir Mazur, Pawel Winter, Krzysztof Kozak, Agnieszka Jagiello- Gruszfeld, Marcin Napierala, Zbigniew Nowecki
Purpose: Mastectomies with immediate reconstruction are the standard of treatment method in patients with breast cancer who cannot be treated with conserving breast surgery. The use of meshes in reconstructive breast surgery has become a gold standard. The purpose of the study was to analyse the complications and own experience after mastectomies with immediate breast reconstruction with the use of Serasynth and SeragynBR synthetic meshes.
Methods: In the period from December 2017 to July 2020, 118 reconstructive surgeries of the breast were performed in the Department of Breast Cancer and Reconstructive Surgery in Maria Sklodowska – Curie Memorial Cancer Center and Institute of Oncology in Warsaw, Poland with the use of SeragynBR and Serasynth meshes in 93 patients operated for breast cancer. 78 Serasynth meshes (Group1) and 40 SeragynBR meshes (Group1I) were implanted.
Results: The most common complication was persistent seroma collection, which was reported in 17.9% of cases in Group1 and 25% in Group1I. Skin inflammation was reported in 7.6% and 17.5%, while infections in 2.5% and 5% of the surgically treated breasts of Group1 and Group2 patients. Reoperation was required in 5.1% and 5% of the patients in Group1 and Group2. The percentage of complications was lower when Serasynth rather than Seragyn BR meshes were implanted. The frequent incidence of the seroma collection did not contribute in any significant way to serious complications such as the need for removal of mesh/implant or infection. The complications, which developed following the implantation of both mesh types, were similar to those presented in other publications concerning mastectomy with a simultaneous breast reconstruction with synthetic meshes. The percentage of implant losses/explanations in the discussed group of patients was lower than that reported in literature.
Conclusion: Despite the complications, both types of meshes can be considered as safe additions to reconstructive breast surgeries.